Luo D - Search Results

1

A low molecular weight multifunctional theranostic molecule for the treatment of prostate cancer.

Wang X, Sun R, Wang J, Li J, Walker E, Shirke A, Ramamurthy G, Shan L, Luo D, Carmon L, Basilion JP. Wang X, et al. Among authors: luo d. Theranostics. 2022 Feb 21;12(5):2335-2350. doi: 10.7150/thno.68715. eCollection 2022. Theranostics. 2022. PMID: 35265213 Free PMC article.

2

Photodynamic Therapy Is an Effective Adjuvant Therapy for Image-Guided Surgery in Prostate Cancer.

Wang X, Ramamurthy G, Shirke AA, Walker E, Mangadlao J, Wang Z, Wang Y, Shan L, Schluchter MD, Dong Z, Brady-Kalnay SM, Walker NK, Gargesha M, MacLennan G, Luo D, Sun R, Scott B, Roy D, Li J, Basilion JP. Wang X, et al. Among authors: luo d. Cancer Res. 2020 Jan 15;80(2):156-162. doi: 10.1158/0008-5472.CAN-19-0201. Epub 2019 Nov 12. Cancer Res. 2020. PMID: 31719100 Free PMC article.

3

Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer.

Wang X, Shirke A, Walker E, Sun R, Ramamurthy G, Wang J, Shan L, Mangadlao J, Dong Z, Li J, Wang Z, Schluchter M, Luo D, Wang Y, Stauffer S, Brady-Kalnay S, Hoimes C, Lee Z, Basilion JP. Wang X, et al. Among authors: luo d. Cancers (Basel). 2021 Jan 22;13(3):417. doi: 10.3390/cancers13030417. Cancers (Basel). 2021. PMID: 33499427 Free PMC article.

4

Targeted Gold Nanocluster-Enhanced Radiotherapy of Prostate Cancer.

Luo D, Wang X, Zeng S, Ramamurthy G, Burda C, Basilion JP. Luo D, et al. Small. 2019 Aug;15(34):e1900968. doi: 10.1002/smll.201900968. Epub 2019 Jul 2. Small. 2019. PMID: 31265213 Free PMC article.

5

Prostate-specific membrane antigen targeted gold nanoparticles for prostate cancer radiotherapy: does size matter for targeted particles?

Luo D, Wang X, Zeng S, Ramamurthy G, Burda C, Basilion JP. Luo D, et al. Chem Sci. 2019 Jul 18;10(35):8119-8128. doi: 10.1039/c9sc02290b. eCollection 2019 Sep 21. Chem Sci. 2019. PMID: 31588336 Free PMC article.

6

Targeted Radiosensitizers for MR-Guided Radiation Therapy of Prostate Cancer.

Luo D, Johnson A, Wang X, Li H, Erokwu BO, Springer S, Lou J, Ramamurthy G, Flask CA, Burda C, Meade TJ, Basilion JP. Luo D, et al. Nano Lett. 2020 Oct 14;20(10):7159-7167. doi: 10.1021/acs.nanolett.0c02487. Epub 2020 Aug 31. Nano Lett. 2020. PMID: 32845644 Free PMC article.

7

Targeted Chemoradiotherapy of Prostate Cancer Using Gold Nanoclusters with Protease Activatable Monomethyl Auristatin E.

Luo D, Wang X, Walker E, Springer S, Ramamurthy G, Burda C, Basilion JP. Luo D, et al. ACS Appl Mater Interfaces. 2022 Apr 6;14(13):14916-14927. doi: 10.1021/acsami.1c23780. Epub 2022 Mar 22. ACS Appl Mater Interfaces. 2022. PMID: 35316026 Free PMC article.

8

Photodynamic Therapy: Targeting Cancer Biomarkers for the Treatment of Cancers.

Wang X, Luo D, Basilion JP. Wang X, et al. Among authors: luo d. Cancers (Basel). 2021 Jun 15;13(12):2992. doi: 10.3390/cancers13122992. Cancers (Basel). 2021. PMID: 34203805 Free PMC article. Review.

9

Magnetic Resonance Imaging of PSMA-Positive Prostate Cancer by a Targeted and Activatable Gd(III) MR Contrast Agent.

Li H, Luo D, Yuan C, Wang X, Wang J, Basilion JP, Meade TJ. Li H, et al. Among authors: luo d. J Am Chem Soc. 2021 Oct 20;143(41):17097-17108. doi: 10.1021/jacs.1c07377. Epub 2021 Oct 6. J Am Chem Soc. 2021. PMID: 34612645

10

Recent Development of Gold Nanoparticles as Contrast Agents for Cancer Diagnosis.

Luo D, Wang X, Burda C, Basilion JP. Luo D, et al. Cancers (Basel). 2021 Apr 11;13(8):1825. doi: 10.3390/cancers13081825. Cancers (Basel). 2021. PMID: 33920453 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,570 results

Search Page